Market Definition
Pharmaceutical Grade Sodium Chloride is the highest purity salt, which is often used in medical applications such as dialysate, replacement fluid, Oral rehydration solution, IV fluids, drug manufacturing, etc. It is 99.99% NaCl and contains 0.1%, or less, of bacteria. However, its use is rising in cosmetic as well as dietary formulations, including baby food, etc.
Market Insights & Analysis: The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market (2023-28):
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market size exceeded 20,000 tons in 2022 & is estimated to grow at a CAGR of around 5.2% during the forecast period, i.e., 2023-28. The market growth imputes to the rising population and increasing healthcare awareness in the Middle East and Africa which has led to higher demand for medicines and medical treatments. As the prevalence of chronic diseases and health issues rises, so does the need for pharmaceutical products, including intravenous solutions and other drugs that utilize sodium chloride as an essential ingredient.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2018-21 |
| Base Year: 2022 | |
| Forecast Period: 2023-28 | |
| CAGR (2023-2028) | 5.2% |
| Country Covered | The UAE, Saudi Arabia, Qatar, Israel, Turkey, South Africa, Rest of the Middle East & Africa |
| Key Companies Profiled | AkzoNobel (Nouryon), Hebei Huachen, Sudsalz Gmbh, Domino Salt Ltd., Cargill Incorporated, Tata Chemicals, K+S AG, Cheetham Salt, Swiss Saltworks, US Salts, Others |
| Unit Denominations | USD Million/Billion |
Additionally, the growing incidence of diseases like diabetes, hypertension, and cardiovascular disorders has propelled the demand for various medications and treatments that require pharmaceutical-grade sodium chloride as a key component. The region's changing lifestyle and dietary habits have contributed to the surge in such health conditions, leading to increased demand for pharmaceutical products. Thus, to cater to the emerging demand for essential medications to treat these diseases, the country is witnessing a rise in partnerships among drug manufacturers to boost local drug development activities. For instance,
Further, the region is witnessing a rising focus of the government to promote its service-based industries which include the healthcare sector to increase their revenue opportunities. Owing to this rise in healthcare sector, research & development activities also have increased. For instance, according to the UAE Ministry of Economy, the pharma manufacturing sector in the UAE alone is expected to rise around USD 5.61 billion in 2027 from just USD 3.08 Billion in 2018 due to the growing expansion of manufacturing activities and rising R&D for drug manufacturing in the country. Thus, this would widely support the demand for Pharmaceutical Grade Sodium Chloride in the Middle East and Africa during 2023-2028.
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Driver:
Surging Investments in the Healthcare Sector of the Region – Many Middle Eastern and African governments have been encouraging the expansion of the pharmaceutical sector which has been in line with fostering economic progress and enhancing public health. For instance, in 2021, the UAE announced its plans to increase investments in the pharmaceutical industry by 20% and to expand its export reach in the region. Moreover, governments across countries like the UAE, Saudi Arabia, etc., have been offering financial incentives, and creating regulatory frameworks, to attract several pharmaceutical manufacturers across their countries.
Further, with the surging expansion of new healthcare facilities, including hospitals and surgical clinics, the demand for Pharmaceutical Grade Sodium Chloride would continue to boom for intravenous therapies, pre & post-operative care, etc. For instance:
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Opportunity:
Rising Prevalence of Renal Patients and Diabetic Cases in the Middle East & African Region– The rising prevalence of renal patients and diabetic cases in the Middle East and African region is significantly impacting the demand for pharmaceutical-grade sodium chloride. Both chronic kidney disease (CKD) and diabetes are conditions that often require the use of intravenous solutions containing sodium chloride for various medical treatments and management of complications.
As the number of patients with these conditions increases, the demand for pharmaceutical-grade sodium chloride for intravenous therapy, diabetic ketoacidosis, dehydration and electrolyte maintenance, and dialysis procedures also increases. This is a key opportunity anticipated to drive market growth in the forecast years. For instance,
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Challenge:
Expensive Renal Care Therapy in the Middle East– Renal care therapies which include dialysis, peritoneal dialysis, etc., are expensive as the therapy is recurring. Thus increased expenses of renal care have forced many of the patients in the Middle Eastern countries to move to Egypt, among other foreign countries to take renal therapies which have been one of the challenges restricting the demand for Pharmaceutical Grade Sodium Chloride in the Middle East specifically.
Moreover, the kidney transplantation cost for the Middle Eastern countries is also on the higher side when compared to African and Asian economies with lower availability of donors which further affects the demand for dialysis-based solutions as patients opt for medical consultation in other lower-expense countries. This acts as a key challenge for the market.
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Trend:
Increasing Demand for Healthcare Services Driven by Private Health Insurance – The expanding role of the private sector in the Middle Eastern health insurance market is a key trend driving the market growth. Private insurance providers are increasingly covering a range of medical conditions, including tuberculosis, cancer, lifestyle diseases, and renal diseases. This comprehensive coverage provided by private vendors such as Pacific Prime Insurance Brokers Limited (PPIB), Orient Takaful Insurance, etc., is widely contributing to the increased demand for healthcare services in the region.
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market (2023-28): Segmentation Analysis
The Middle East & Africa Pharmaceutical Grade Sodium Chloride Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2023–2028 at the regional level. Based on the analysis, the market has been further classified as:
Based on Application:
Hemodialysis is anticipated to hold a substantial market share in the Middle East & Africa Pharmaceutical Grade Sodium Chloride market in the forecast years driven by the rising health concerns related to kidney failures in the region. According to Cleveland Clinic Abu Dhabi as of 2020, the UAE alone registered over 2000 cases of end-stage renal diseases, with a significant number of populations suffering from 1st and 2nd state kidney diseases. Owing to this, the demand for kidney transplants in the country is substantial, which leads to the requirement for sodium chloride in hospitals for Dialysate Preparation, Electrolyte Balance, establishing Osmotic Pressure, fluid balance, etc.
For instance, the UAE-based Sheikh Khalifa Medical City announced that it has performed over 72 kidney transplants alone in 2022. As compared to just 49 in 2021.
Moreover, as the region has a high prevalence of diabetic and hypertension patients, due to a sedentary lifestyle, genetic and other environmental factors, the demand for kidney dialysis is anticipated to rise in the future. This would widely promote the demand for pharmaceutical-grade sodium chloride in the region in the coming years as well.
Middle East Pharmaceutical Grade Sodium Chloride Market (2023-28): Regional Analysis
Geographically, the Middle East & Africa Pharmaceutical Grade Sodium Chloride Market expands across:
Among them, the UAE registered a considerable growth rate in the Middle East and Africa Pharmaceutical Grade Sodium Chloride market. The United Arab Emirates (UAE) has a robust government-funded as well as a fast-growing private healthcare sector. The increasing number of expatriates and the local population in the UAE has stressed the requirement for improving healthcare services by increasing healthcare infrastructure as well as increasing pharmaceutical drug production within the country.
The demand for renal care centers has also witnessed an increase in the country, owing to the growing prevalence of hypertension and diabetes among the residents in the UAE. Additionally, the UAE Ministry of Health & Prevention is aiming to reduce hypertension prevalence to 21.8% by 2025 through intensifying awareness campaigns and promoting early detection via periodic examination services. As a result, the demand for Pharmaceutical Grade Sodium Chloride will continue to augment in the country, for early detection and disease prevention in the coming years as well.
Gain a Competitive Edge with Our Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Report
Frequently Asked Questions
A. The Middle East & Africa Pharmaceutical Grade Sodium Chloride market is anticipated to register a CAGR of over 5.2% during 2023-28.
A. Surging investments in the expansion of healthcare facilities are notably supporting the market growth.
A. AkzoNobel (Nouryon), Hebei Huachen, Sudsalz Gmbh, Domino Salt Ltd., Cargill Incorporated, Tata Chemicals, K+S AG, Cheetham Salt, Swiss Saltworks, US Salts, etc., are some of the key players operating in the market.
A. Hemodialysis is a leading application in the Middle East & Africa Pharmaceutical Grade Sodium Chloride market.
A. The UAE is anticipated to register a considerable growth rate in the Middle East & Africa Pharmaceutical Grade Sodium Chloride market during 2023-28.
A. Increasing demand for healthcare services driven by private health insurance is a key trend shaping the Middle East & Africa Pharmaceutical Grade Sodium Chloride Market.
A. The rising prevalence of renal patients and diabetic cases in the Middle East & Africa region is anticipated to drive the market growth during 2023-28.
A. Expensive renal care therapy in the Middle East leading to a rise in outbound medical tourism to African economies including Egypt, is one of the possible restraints affecting the growth of the Middle East & Africa Pharmaceutical Grade Sodium Chloride Market.
Middle East & Africa Pharmaceutical Grade Sodium Chloride Market Research Report (2023-2028) - Table of Contents
